Okupe Oluyemi's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Oct 16, 2024
- Accession no.
- 0001773751-24-000321
- Filed
- Oct 16, 2024
- Trade date
- Oct 14, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 2 derivative transactions. Open-market sales total $5.48M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Okupe OluyemiCIK 0001907056 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 14, 2024 | Class A Common Stock | MOption exerciseAcquired | +11,700 | $11.53 | +$134,901 | 207,688 | Direct | |
| Oct 14, 2024 | Class A Common Stock | MOption exerciseAcquired | +207,814 | $5.01 | +$1,041,148.14 | 415,502 | Direct | |
| Oct 14, 2024 | Class A Common Stock | SSaleDisposed | −2,388 | $20.00F2 | −$47,760 | 413,114 | Direct | |
| Oct 14, 2024 | Class A Common Stock | SSaleDisposed | −9,193 | $19.95F3 | −$183,400.35 | 403,921 | Direct | |
| Oct 14, 2024 | Class A Common Stock | SSaleDisposed | −6,326 | $19.95 | −$126,203.7 | 397,595 | Direct | |
| Oct 14, 2024 | Class A Common Stock | SSaleDisposed | −40,132 | $19.98F4 | −$801,837.36 | 357,463 | Direct | |
| Oct 14, 2024 | Class A Common Stock | SSaleDisposed | −11,700 | $20.04F5 | −$234,468 | 345,763 | Direct | |
| Oct 14, 2024 | Class A Common Stock | SSaleDisposed | −183,600 | $20.37F6 | −$3,739,932 | 162,163 | Direct | |
| Oct 14, 2024 | Class A Common Stock | SSaleDisposed | −16,400 | $21.07F7 | −$345,548 | 145,763 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 14, 2024 | Class A Common Stock | MOption exerciseDisposed | −11,700 | $0.00 | $0 | 91,832 | Direct | |
| Oct 14, 2024 | Class A Common Stock | MOption exerciseDisposed | −207,814 | $0.00 | $0 | 620,033 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.00 - $20.005. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.82 - $20.015 The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.95 - $20.02. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.02 - $20.045. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.045 - $20.99. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $21.00 - $21.18. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.